Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...

ALEX TORDOFF is relishing the prospect of fulfilling a lifelong dream as he saddles up for his Defender Burghley Horse Trials debut.

HBAR tests key support at $0.23 after a 3% pullback Friday, with resistance forming near $0.24. Bullish catalysts emerge as ...

The Air Force has issued guidance on how transgender Airmen and Guardians will be involuntarily discharged, making it the ...

The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers (ACCC), sat down for an interview with CURE to discuss the need for ...

The company plans to continue with a lower dose and a change in the pre-treatment regimen after a trial participant died ...

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...

Clinical trials test the safety and effectiveness of new cancer drugs and treatments. Search for Huntsman Cancer Institute clinical trials by cancer type, drug, or doctor.

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and new therapeutic targets fueling cautious hope.